Your session is about to expire
← Back to Search
Collaborative Dementia Care Program for Alzheimer's Disease (COADS Trial)
N/A
Waitlist Available
Led By Nicole Fowler, PHD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 month
Awards & highlights
COADS Trial Summary
This trial will test if early diagnosis and intervention can reduce caregiver burden for Alzheimer's disease.
COADS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Short Form Health Survey (SF-36)
Secondary outcome measures
Anxiety symptoms
Caregiving preparedness
Caregiving self efficacy
+1 moreCOADS Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative Dementia Care ProgramExperimental Treatment1 Intervention
The patients in this group will receive screening for AD, Patients and family members will receive a letter about how the patient performed on the screening. If they screen positive (e.g. ≤5 on the MIS-T or ≤2 on the Mini-Cog), the patient and family member will receive an infographic. Also, the family member will receive two follow-up phone calls. One from the COADS Study Coordinator and one from a care coordinator at the Aging Brain Care Program (ABC). This phone call will include an opportunity for the family to ask questions and a conversation about the program and diagnostic evaluation and management. Dyads have the option to refuse the follow-up visit. The patient's PCP is also be notified of the screening results via EHR message,
Group II: ControlActive Control1 Intervention
The patients in this group will receive no AD screening
Group III: Screening OnlyActive Control1 Intervention
The patients in this group will receive screening for AD. Patients and family members will receive a letter about how the patient performed on the screening. If they screen positive (e.g. ≤5 on the MIS-T or ≤2 on the Mini-Cog), the patient and family member will receive an infographic and some information about local clinical resources for them to peruse regarding follow-up care. The patient's PCP is also be notified of the screening results via EHR message.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Collaborative Dementia Care Program
2012
N/A
~7740
Find a Location
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,948,805 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,013,329 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
979,337 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I'm sorry, but "Family Members" is not specific enough to be a screening criterion. Can you please provide more information or context?You must be at least 21 years old.You understand the study and agree to participate in it.You are able to understand the study and agree to participate in it.You have told us who you would like to take care of you if needed.You live with the patient or within 50 miles of the study site.Criterion: IndividualsYou are 65 years of age or older.You need to be able to speak and understand English.You have visited a primary care doctor at least once in the last 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: Collaborative Dementia Care Program
- Group 2: Control
- Group 3: Screening Only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for new participants in this experiment?
"The clinical trial information hosted on clinicaltrials.gov reveals that this particular study, initially posted in October of 2018, is not presently seeking participants. Despite the fact that this investigation has concluded recruitment for now, there are still 548 other trials looking for volunteers at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger